Petro Bagriy, president of the Association of Drug Manufacturers of Ukraine (AMMU), which gathers seven of the leading Ukrainian pharmaceutical companies, provides insights into the internal workings of the association and the interaction with the government, the future direction and strategies of AMMU as well as how the new reforms have influenced the actions of the AMMU members and the Ukrainian healthcare system in general.
Could you please elaborate to our international readers why leading Ukrainian pharmaceutical companies came together to form the AMMU in 1996?
"Companies that initially were against GMP have now come to the realization that it allows domestic companies to sell products all around the world. As a consequence, Ukrainian companies now distribute their products to 56 nations, compared to pre-GMP years when they only exported to Post-Soviet states."
